Found in Translation: How Innovations in Product R&D Can Solve the World’s Toughest Health Challenges
Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries. He manages the foundation’s disease-specific R&D investments in HIV, tuberculosis, malaria, pneumonia, enteric and diarrheal diseases and neglected tropical diseases. He also manages cross-cutting product development programs, including Discovery & Translational Sciences, Innovative Technology Solutions, Integrated Development, and Vaccine Development & Surveillance. Born and raised in South Africa, Mundel earned his bachelor’s and medical degrees from the University of the Witwatersrand in Johannesburg. He also studied mathematics, logic and philosophy as a Rhodes Scholar at Oxford University, and he earned a PhD in mathematics at the University of Chicago.
The inaugural Spectrum symposium, hosted on February 20, 2019 in La Jolla, California, convened thought leaders from across the country for discussions around accelerating delivery of novel medicines to the patients desperately in need of new therapies. Over 200 attendees– foundation representatives, philanthropists, biopharma leaders, healthcare investors and research scientists– listened to Scripps Research scientists share their basic and translational research efforts. The symposium inspired follow-up discussions about potential initiatives and collaborations to impact public health.